#  Discordant Clostridioides difficile diagnostic assay and treatment practice: a cross-sectional study in a tertiary care hospital, Geneva, Switzerland 
A sample readme to match database of this study

## Description
To determine the proportion of patients who received a treatment for Clostridioides difficile infection (CDI) among those presenting a discordant Clostridioides difficile diagnostic assay and to identify patient characteristics associated with the decision to treat CDI. 

## List of variable 
- Gender
  - 1 = female
  - 0 = male 
  
- Age
  - At the time of test prescription
  
- Patient's location 
  - Patient's location at the time of test prescription. Inpatients are classified regarding hospital unit. 
  
- Outpatient
  - Patients with ambulatory care at the time of test prescription
  
- Inpatient (yes=1)
  - Hospitalized patients at the time of test prescription or patients in the emergency room. 
  
- Risk factor ≥ 65 yo (yes=1)
  - Age of ≥ 65 years old at the time of test prescription
  
- Risk factor history of hospitalisation (yes=1)
  - History of an hospitalisation of ≥ 48 hours in the past 12 weeks before test prescription 
  
- Risk factor history of C.difficile (yes=1)
  - All patients with a history of positive test results (NAAT+ or EIA+ or TC+) who had received a treatment for CDI 

- Risk factor history of antibiotic therapy (yes=1) 
  - History of any antibiotic treatment of ≥ 48 hours in the past 12 weeks before test prescription 
  
- Risk factor ongoing treatment of inhibitory proton pump inhibitor IPP (yes=1)
  - Patients with any ongoing proton pump inhibitor treatment at the moment of test prescription 

- Risk factor immunosuppression (yes=1)
  - Patients with chemotherapy within the 60 days before test prescription; SOT (solid organ transplant) patients, HSCT (hematopoietic stem cell transplant) patients, ongoing steroid treatment 
  
- Risk factor chronic kidney disease (yes=1)
  - Patient with a known chronic renal insuffisiency defined as a creatinine clearance < 60ml/min 
  
- Risk factor obesity (yes=1)
  - Patients with a body mass index ≥ 30 
  
- Diarrhea at the time of testing (yes=1)
  - patients with ≥ 3 unformed stools in 24 h. 

- Imaging (yes=1)
  - any abdominal imaging
  
- Delay between imaging and treatment introduction (days)
  - negative value: imaging before treatment introduction
  - positive value: imaging after treatment introduction 
  
- Delay between imaging and test result (days)
  - negative value: imaging before test result introduction
  - positive value: imaging after test result introduction
  
- Abdominal CT-scan (yes=1)

- Indication for CT-scan: suspicion of colitis (yes=1)
  - The suspicion of C. difficile colitis was the major indication for abdominal CT-scan
  
- Indication of CT-scan: suspicion of C. difficile complication (yes=1)
  - The suspicion of C. difficile colitis complication (perforation, toxic megacolon, ileus) was the major indication for abdominal CT-scan
  
- Indication of CT-scan: suspicion of abdominal infection (yes=1)
  - The suspicion of unspecified abdominal infection was the major indication for abdominal CT-scan
  
- Indicaton of CT-scan: suspicion of urological disease (yes=1)
  - The suspicion of an urological disease was the major indication for abdominal CT-scan
  
- Indication of CT-scan: oncologic disease (yes=1)
  - The suspicion of an oncologic disease was the major indication for abdominal CT-scan
  
- Indication of CT-scan: suspicion of osteo-articular disease (yes=1)
  - The suspicion of an osteo-articular disease (arthritis, fracture) was the major indication for abdominal CT-scan
  
- CT-scan results: signs of colitis (yes=1)
  - Any patient with signs of colitis visualized on abdominal CT-scan
  
- Rectosigmoidoscopy (yes=1)
  - Patient who underwent rectosigmoidoscopy 
  
- Rectosigmoidoscopy with typical signs of C. difficile (yes=1)
  - Patient who underwent rectosigmoidoscopy and who had typical C. difficile endoscopic lesions
  
- Severity criteria (yes=1)
- Complicatied (yes=1)
- Complicated (definition)
- Treatement (yes=1) 
- Delay between test result and treatment introduction (days)
- Treatment duration (days)
- Molecule
- Infectious disease specialist advice (yes=1)
- Reason for incomplete treatment duration(death=1/other=0)
- Presence of an alternative diagnosis in EMR (yes=1) 


## Variable removed from the original dataset 
